Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium
Conditions
Interventions
Intervention1: Comparison of intravenous iron isomaltoside versus blood transfusion for the treatment of moderate anemia in postpartum women.: The Iv iron group will receive Intravenous iron isomaltos
Sponsors
Rajendra institute of medical sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1. women clinically anemic or complicated with anemic symptoms irrespective of mode of delivery with hemoglobin measured 12hrs after delivery ranging between 7-9g/dl. 2. women who are willing to participate in the study and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Women with hemodynamic instability. 2. Women with history of Blood transfusion during pregnancy or after delivery 3. Women with multiple allergies,or any acute infection. 4. Women with any hemoglobinopathies.or hemolytic anemia or any chronic illness like chronic liver disease, chronic kidney disese, HELLP syndrome etc. 5. Women with history of adverse events following any injectable iron preparations in the past. 6. Women with known case of iron overload or disturbance in iron absorption eg.Hemochromatosis, Hemosiderosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effectiveness of intravenous iron isomaltoside vs blood transfusion in treatment of moderate anemia in postpartum females.Timepoint: At baseline,3rd week and 6th week. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the number ,type of adverse effects with iv iron isomaltoside vs blood transfusion.Timepoint: Day 1 ,6th week | — |
Countries
India
Contacts
Public ContactKritika Srivastava
Rims,Ranchi
Outcome results
None listed